UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Human cytomegalovirus hijacks the autophagic machinery and LC3 homologs in order to optimize cytoplasmic envelopment of mature infectious particles

Scientific reports, 2019-03, Vol.9 (1), p.4560-4560, Article 4560

2019

Volltextzugriff (PDF)

The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1

Journal of Virology, 2012-03, Vol.86 (5), p.2571-2584

2012

Volltextzugriff (PDF)

Transfusion-Transmitted Hepatitis E Virus Infection in France

Transfusion medicine reviews, 2019-07, Vol.33 (3), p.146-153

2019

Volltextzugriff (PDF)

Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins

Autophagy, 2016-01, Vol.12 (2), p.327-342

2016

Volltextzugriff (PDF)

Transfusion-Transmitted Hepatitis A Virus, France, 2018

Emerging infectious diseases, 2022-01, Vol.28 (1), p.219-223

2022

Volltextzugriff (PDF)

Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls

Journal of hematology and oncology, 2021-10, Vol.14 (1), p.1-166, Article 166

2021

Volltextzugriff (PDF)

Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers

Viruses, 2023-02, Vol.15 (2), p.426

2023

Volltextzugriff (PDF)

Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report

BMC infectious diseases, 2021-12, Vol.21 (1), p.1223-1223, Article 1223

2021

Volltextzugriff (PDF)

Contribution of Serum Cytomegalovirus PCR to Diagnosis of Early CMV Primary Infection in Pregnant Women

Viruses, 2022-09, Vol.14 (10), p.2137

2022

Volltextzugriff (PDF)

Comparison of serum and plasma viral load measurements in human immunodeficiency virus type 1 infection

Journal of clinical virology plus, 2023-02, Vol.3 (1), p.100127, Article 100127

2023

Volltextzugriff (PDF)

Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines

Journal of clinical virology plus, 2021-12, Vol.1 (4), p.100055, Article 100055

2021

Volltextzugriff (PDF)

BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction

Autophagy, 2021-06, Vol.17 (6), p.1296-1315

2021

Volltextzugriff (PDF)

Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases

Arthritis & rheumatology (Hoboken, N.J.), 2022-06, Vol.74 (6), p.927-933

2022

Volltextzugriff (PDF)

Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples

Journal of clinical virology, 2020-05, Vol.126, p.104331-104331, Article 104331

2020

Volltextzugriff (PDF)

SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population

The Science of the total environment, 2022-03, Vol.810, p.152213-152213, Article 152213

2022

Volltextzugriff (PDF)

Feasibility, performances and predictive value of congenital CMV neonatal screening on saliva swabs

Journal of clinical virology, 2024-10, Vol.174, p.105713, Article 105713

2024

Volltextzugriff (PDF)

Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold

Journal of clinical virology, 2022-01, Vol.146, p.105059-105059, Article 105059

2022

Volltextzugriff (PDF)

Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment

IJID regions, 2024-06, Vol.11, p.100374-100374, Article 100374

2024

Volltextzugriff (PDF)

Correction for Chaumorcel et al., "The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1"

Journal of virology, 2018-05, Vol.92 (9), p.e00252-18

2018

Volltextzugriff (PDF)

Invasive meningoencephalitis as the first manifestation of hepatitis A

Journal of viral hepatitis, 2019-11, Vol.26 (11), p.1330-1333

2019

Volltextzugriff (PDF)

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients

Clinical kidney journal, 2021-12, Vol.14 (12), p.2616-2617

2021

Volltextzugriff (PDF)

Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018

Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-07, Vol.23 (27), p.1

2018

Volltextzugriff (PDF)

Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017

Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-05, Vol.23 (21), p.1

2018

Volltextzugriff (PDF)

Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018

Euro surveillance : bulletin européen sur les maladies transmissibles, 2019-11, Vol.24 (47)

2019

Volltextzugriff (PDF)

Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly

Open forum infectious diseases, 2022-11, Vol.9 (11), p.ofac613-ofac613

2022

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(40)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human cytomegalovirus hijacks the autophagic machinery and LC3 homologs in order to optimize cytoplasmic envelopment of mature infectious particles

The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1

Transfusion-Transmitted Hepatitis E Virus Infection in France

Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins

Transfusion-Transmitted Hepatitis A Virus, France, 2018

Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls

Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers

Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report

Contribution of Serum Cytomegalovirus PCR to Diagnosis of Early CMV Primary Infection in Pregnant Women

Comparison of serum and plasma viral load measurements in human immunodeficiency virus type 1 infection

Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines

BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction

Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases

Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples

SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population

Feasibility, performances and predictive value of congenital CMV neonatal screening on saliva swabs

Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold

Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment

Correction for Chaumorcel et al., "The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1"

Invasive meningoencephalitis as the first manifestation of hepatitis A

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients

Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018

Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017

Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018

Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly

Suchergebnisse filtern